SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028596
Filing Date
2022-08-09
Accepted
2022-08-09 08:12:38
Documents
58
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q prld-10q_20220630.htm   iXBRL 10-Q 3760241
2 EX-10.1 prld-ex101_183.htm EX-10.1 59184
3 EX-31.1 prld-ex311_8.htm EX-31.1 22741
4 EX-31.2 prld-ex312_6.htm EX-31.2 22766
5 EX-32.1 prld-ex321_9.htm EX-32.1 10239
6 EX-32.2 prld-ex322_10.htm EX-32.2 10329
  Complete submission text file 0001564590-22-028596.txt   8859207

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA prld-20220630.xsd EX-101.SCH 39370
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prld-20220630_cal.xml EX-101.CAL 37007
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prld-20220630_def.xml EX-101.DEF 156993
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prld-20220630_lab.xml EX-101.LAB 339632
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prld-20220630_pre.xml EX-101.PRE 261956
52 EXTRACTED XBRL INSTANCE DOCUMENT prld-10q_20220630_htm.xml XML 1248580
Mailing Address 200 POWDER MILL ROAD WILMINGTON DE 19803
Business Address 200 POWDER MILL ROAD WILMINGTON DE 19803 (302) 547-3768
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39527 | Film No.: 221146507
SIC: 2834 Pharmaceutical Preparations